Shares of International Biotechnology (LON:IBT – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 946.83 and traded as high as GBX 960. International Biotechnology shares last traded at GBX 956, with a volume of 62,941 shares.
International Biotechnology Trading Up 0.8%
The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The firm’s fifty day moving average is GBX 969.14 and its two-hundred day moving average is GBX 946.83. The firm has a market cap of £304.28 million, a P/E ratio of 3.95 and a beta of 0.52.
International Biotechnology (LON:IBT – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The company had revenue of GBX 24 million during the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%. Analysts predict that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Featured Articles
- Five stocks we like better than International Biotechnology
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
- Alphabet’s Most Overlooked Division Just Had a Big Week
- Cooking Up Profits: Cracker Barrel’s Turnaround
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
